FDA Clears Revi Extend Implant for Urgency Urinary Incontinence with Extended Lifespan

The FDA has granted 510(k) clearance to Revi Extend, an updated implantable tibial neuromodulation system for treating urgency urinary incontinence (UUI). The new device features an extended lifespan of 15 years, an increase from the previous 10 years, offering a longer-term solution for patients.